(AMCR) Amcor - Ratings and Ratios
Flexible Packaging, Rigid Packaging, Closures, Containers, Pharma Devices
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.14% |
| Yield on Cost 5y | 5.67% |
| Yield CAGR 5y | 2.09% |
| Payout Consistency | 94.0% |
| Payout Ratio | 70.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.8% |
| Value at Risk 5%th | 35.4% |
| Relative Tail Risk | -1.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.47 |
| Alpha | -18.93 |
| CAGR/Max DD | -0.24 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.524 |
| Beta | 0.513 |
| Beta Downside | 0.310 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.20% |
| Mean DD | 14.43% |
| Median DD | 15.43% |
Description: AMCR Amcor December 19, 2025
Amcor plc (NYSE: AMCR) is a global packaging company headquartered in Zurich, Switzerland, operating through two business segments: Global Flexible Packaging Solutions, which supplies polymer-, aluminum-, and fiber-based flexible films to food, beverage, medical, and personal-care markets; and Global Rigid Packaging Solutions, which produces rigid containers, closures, and dispensing devices primarily for food and beverage applications. The firm serves customers across Europe, North America, Latin America, and the Asia-Pacific via a direct sales force and has been in operation since 1926.
Key recent metrics (FY 2023) include revenue of approximately $15.4 billion, an adjusted EBITDA margin of 13.2 %, and a net debt-to-EBITDA ratio of 2.1 ×, reflecting a moderate leverage profile. The packaging sector is currently driven by three macro forces: (1) tightening sustainability regulations that favor recyclable and lightweight materials; (2) volatile raw-material costs, especially for resin and aluminum, which compress margins; and (3) a secular shift toward e-commerce and on-the-go consumption, boosting demand for flexible packaging formats.
For a deeper quantitative view of AMCR’s valuation metrics, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (582.0m TTM) > 0 and > 6% of Revenue (6% = 1.04b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 0.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.98% (prev 8.63%; Δ -6.66pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 1.53b > Net Income 582.0m (YES >=105%, WARN >=100%) |
| Net Debt (14.97b) to EBITDA (2.19b) ratio: 6.85 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.59b) change vs 12m ago 10.32% (target <= -2.0% for YES) |
| Gross Margin 18.96% (prev 20.12%; Δ -1.16pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.38% (prev 80.13%; Δ -15.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.53 (EBITDA TTM 2.19b / Interest Expense TTM 486.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.39
| (A) 0.01 = (Total Current Assets 8.53b - Total Current Liabilities 8.19b) / Total Assets 37.15b |
| (B) 0.01 = Retained Earnings (Balance) 516.0m / Total Assets 37.15b |
| (C) 0.05 = EBIT TTM 1.23b / Avg Total Assets 27.03b |
| (D) -0.02 = Book Value of Equity -498.0m / Total Liabilities 25.42b |
| Total Rating: 0.39 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 53.42
| 1. Piotroski 2.0pt |
| 2. FCF Yield 4.52% |
| 3. FCF Margin 8.84% |
| 4. Debt/Equity 1.35 |
| 5. Debt/Ebitda 6.85 |
| 6. ROIC - WACC (= 0.72)% |
| 7. RoE 7.49% |
| 8. Rev. Trend 32.78% |
| 9. EPS Trend -23.67% |
What is the price of AMCR shares?
Over the past week, the price has changed by +2.07%, over one month by +0.57%, over three months by +2.64% and over the past year by -8.92%.
Is AMCR a buy, sell or hold?
- Strong Buy: 3
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AMCR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.4 | 24.4% |
| Analysts Target Price | 10.4 | 24.4% |
| ValueRay Target Price | 8.8 | 5.6% |
AMCR Fundamental Data Overview December 10, 2025
P/E Trailing = 27.5
P/E Forward = 10.395
P/S = 1.0944
P/B = 1.635
P/EG = 0.5224
Beta = 0.681
Revenue TTM = 17.40b USD
EBIT TTM = 1.23b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 12.82b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 15.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 14.97b USD (from netDebt column, last quarter)
Enterprise Value = 34.02b USD (19.04b + Debt 15.80b - CCE 825.0m)
Interest Coverage Ratio = 2.53 (Ebit TTM 1.23b / Interest Expense TTM 486.0m)
FCF Yield = 4.52% (FCF TTM 1.54b / Enterprise Value 34.02b)
FCF Margin = 8.84% (FCF TTM 1.54b / Revenue TTM 17.40b)
Net Margin = 3.34% (Net Income TTM 582.0m / Revenue TTM 17.40b)
Gross Margin = 18.96% ((Revenue TTM 17.40b - Cost of Revenue TTM 14.10b) / Revenue TTM)
Gross Margin QoQ = 19.56% (prev 17.61%)
Tobins Q-Ratio = 0.92 (Enterprise Value 34.02b / Total Assets 37.15b)
Interest Expense / Debt = 1.11% (Interest Expense 176.0m / Debt 15.80b)
Taxrate = 15.76% (49.0m / 311.0m)
NOPAT = 1.03b (EBIT 1.23b * (1 - 15.76%))
Current Ratio = 1.04 (Total Current Assets 8.53b / Total Current Liabilities 8.19b)
Debt / Equity = 1.35 (Debt 15.80b / totalStockholderEquity, last quarter 11.72b)
Debt / EBITDA = 6.85 (Net Debt 14.97b / EBITDA 2.19b)
Debt / FCF = 9.73 (Net Debt 14.97b / FCF TTM 1.54b)
Total Stockholder Equity = 7.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.57% (Net Income 582.0m / Total Assets 37.15b)
RoE = 7.49% (Net Income TTM 582.0m / Total Stockholder Equity 7.77b)
RoCE = 5.96% (EBIT 1.23b / Capital Employed (Equity 7.77b + L.T.Debt 12.82b))
RoIC = 5.46% (NOPAT 1.03b / Invested Capital 18.94b)
WACC = 4.74% (E(19.04b)/V(34.84b) * Re(7.90%) + D(15.80b)/V(34.84b) * Rd(1.11%) * (1-Tc(0.16)))
Discount Rate = 7.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 5.18%
[DCF Debug] Terminal Value 78.85% ; FCFE base≈1.19b ; Y1≈1.24b ; Y5≈1.42b
Fair Price DCF = 10.84 (DCF Value 25.03b / Shares Outstanding 2.31b; 5y FCF grow 4.18% → 3.0% )
EPS Correlation: -23.67 | EPS CAGR: 1.88% | SUE: 0.25 | # QB: 0
Revenue Correlation: 32.78 | Revenue CAGR: 14.07% | SUE: -0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.21 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-06-30): EPS=0.81 | Chg30d=+0.004 | Revisions Net=+1 | Growth EPS=+13.3% | Growth Revenue=+53.9%
EPS next Year (2027-06-30): EPS=0.89 | Chg30d=-0.000 | Revisions Net=-1 | Growth EPS=+10.7% | Growth Revenue=+1.6%
Additional Sources for AMCR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle